Inventor
BHAGAT LAKSHMI
US33 patents
⚠️ This page may combine multiple inventors who share the name “BHAGAT LAKSHMI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IDERA PHARMACEUTICALS INC
21 patentsUS7276489B2Oct 2, 2007
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
IDERA PHARMACEUTICALS INC221 citations99
US7812000B2Oct 12, 2010
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
IDERA PHARMACEUTICALS INC66 citations98
US7517862B2Apr 14, 2009
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
IDERA PHARMACEUTICALS INC64 citations98
US7407944B2Aug 5, 2008
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
IDERA PHARMACEUTICALS INC56 citations98
US7851453B2Dec 14, 2010
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
IDERA PHARMACEUTICALS INC17 citations93
US7749975B2Jul 6, 2010
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
IDERA PHARMACEUTICALS INC9 citations93
US7632822B2Dec 15, 2009
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
IDERA PHARMACEUTICALS INC17 citations93
US7569554B2Aug 4, 2009
Synergistic treatment of cancer using immunomers in conjunction with therapeutic agents
IDERA PHARMACEUTICALS INC23 citations93
US7354907B2Apr 8, 2008
Short immunomodulatory oligonucleotides
IDERA PHARMACEUTICALS INC38 citations93
US9453228B2Sep 27, 2016
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC21 citations92
US8361986B2Jan 29, 2013
Synthetic agonists of TLR9
IDERA PHARMACEUTICALS INC18 citations92
US8008267B2Aug 30, 2011
Stabilized immunomodulatory oligonucleotides
IDERA PHARMACEUTICALS INC29 citations92
US7960362B2Jun 14, 2011
Synthetic agonists of TLR9
IDERA PHARMACEUTICALS INC19 citations92
US9206430B2Dec 8, 2015
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC7 citations84
US8383598B2Feb 26, 2013
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC12 citations84
US8377898B2Feb 19, 2013
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC15 citations84
US8357665B2Jan 22, 2013
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
IDERA PHARMACEUTICALS INC10 citations84
US7884197B2Feb 8, 2011
Synthetic agonists of TLR9
IDERA PHARMACEUTICALS INC13 citations84
US7875594B2Jan 25, 2011
Synergistic treatment of cancer using immunomers in conjunction with chemotherapeutic agents
IDERA PHARMACEUTICALS INC11 citations84
US7863250B2Jan 4, 2011
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
IDERA PHARMACEUTICALS INC9 citations84
US8362233B2Jan 29, 2013
Stabilized immune modulatory RNA (SIMRA) compounds
IDERA PHARMACEUTICALS INC5 citations73
KANDIMALLA EKAMBAR
6 patentsUS8426375B2Apr 23, 2013
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
KANDIMALLA EKAMBAR25 citations92
US8853375B2Oct 7, 2014
Toll like receptor modulators
KANDIMALLA EKAMBAR17 citations83
US8399423B2Mar 19, 2013
Immune regulatory oligonucleotide (IRO) compounds to modulate toll-like receptor based immune response
KANDIMALLA EKAMBAR12 citations83
US8188261B2May 29, 2012
Stabilized immune modulatory RNA (SIMRA) compounds
KANDIMALLA EKAMBAR13 citations83
US8153777B2Apr 10, 2012
Modulation of toll-like receptor 5 expression by antisense oligonucleotides
KANDIMALLA EKAMBAR3 citations62
US8153605B2Apr 10, 2012
Modulation of toll-like receptor 3 expression by antisense oligonucleotides
KANDIMALLA EKAMBAR0 citations51
AGRAWAL SUDHIR
3 patentsUS8202850B2Jun 19, 2012
Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5′ ends
AGRAWAL SUDHIR60 citations97
US8431544B1Apr 30, 2013
Compositions for inhibiting gene expression and uses thereof
AGRAWAL SUDHIR48 citations93
US8153608B2Apr 10, 2012
Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
AGRAWAL SUDHIR9 citations84